all the way up green
3 hours ago
Item 5.03 Amendments to Articles of Incorporation
On May 20, 2024 Regen Biopharma, Inc. amended its Certificate of Incorporation adding the following Article 8 which is and reads as follows:
Shares of one class or series of stock may be issued as a share dividend in respect of another class or series.
Item 8.01 Other Events.
On May 21 , 2024 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of June 20,2024 (“Record Date”) to be paid to shareholders on or about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of two share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date
Item 9.01 Financial Statements and Exhibits
all the way up green
3 weeks ago
Item 8.01 Other Events.
On May 21 , 2024 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of June 20,2024 (“Record Date”) to be paid to shareholders on or about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of two share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date.
www.otcmarkets.com
8-k from May 23, 2024
bme
4 weeks ago
Ok. Thanks. Here is the section in that 8k report.
On May 21 , 2024 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of June 20,2024 (“Record Date”) to be paid to shareholders on or about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of two share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date
Fdc4
2 months ago
There’s no proceed with caution when it is about David Koos in Rgbp, It is a dead end, backyards full of beard traps and you are in the middle of them. Only suggestion is to walk away if you have never gambled in here. Now, for those already in it, like me, I have this:
Koos: You’ll not die, but you’ll dry, slowly!!
QUEEN2
2 months ago
[color=red]History of David Koos's life as a con man :
David Koos Scares Me - I just dumped all my shares. I should have done more research into the CEO and the company. It may get pumped again and some may make a little, but this whole thing seems to scammy for my money.
I bought RGBP because they made a deal with OPNH. I really thought they had something... I really wanted this stock to work out. Taking my loss...
You can google "david koos scam" and find all kinds of information.
In 2005, he was part of GISBeX offshore stock exchange scam. He got out early neough to no bet prosecuted. He did not serve jail time, but others did. https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
It is alarming how man issues this Koos guy has run into. I have no idea how I missed it. (https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp)
The item that caught my eye is that he is a CEO of two companies and they both made deals with OPNH. I am not sure how it is all connected, but again seems sketchy.
I hope you all the best, but proceed with caution and do a few google searches."
- From a former shareholder!
https://www.nanalyze.com/2014/03/big-red-flags-from-bio-matrix-and-regen-biopharma/
https://www.reddit.com/r/RGBP/comments/mu215v/david_koos_scares_me/
https://www.reddit.com/r/bestdaytrading/comments/ltzt9u/onph_beware_company_issued_20million_shares_plus/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136607229
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168620243
[/color]
QUEEN2
2 months ago
David Koos' crooked past :
Bio-Matrix Scientific Group, which says it is a biotech in such areas as adult stem-cell cryogenics, was formerly on GISBeX but isn't now. It changed its name from Storage Suites America last December. It keeps pumping out news releases saying it "is preparing to apply for a stem-cell research grant" or is applying for "a cryogenic stem-cell bank certificate" or applying for "International Society of Stem Cell Research" membership and the like. Self-promotion based on applications is not a good sign. "We're a developmental-stage company," explains David Koos, chief executive, who says he doesn't know anything about GISBeX. The stock trades on the so-called pink sheets -- caveat emptor incarnate -- and does not report its results to the Securities and Exchange Commission. The stock has been selling for 34 cents per share.
https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
Sat Naam
2 months ago
anybody recognize this trash (see portion in bold)
(Bloomberg) -- (djt) "just became the most valuable publicly traded client of an accounting firm that has more experience auditing companies traded over-the-counter and has had a string of regulatory issues, including a 100% deficiency rate on audits reviewed by a US watchdog."
(djt) "said in recent regulatory filings that it will keep BF Borgers, a Lakewood, Colorado-based accounting firm, as its auditor after starting to trade publicly late last month. A Canadian regulator said last year that BF Borgers violated its rules for auditors, while the US’s Public Company Accounting Oversight Board found multiple deficiencies in every audit it reviewed from the firm over the past two annual checks."
https://www.dailykos.com/stories/2024/4/8/2234106/-DJT-hires-accounting-firm-with-100-deficiency-record?pm_campaign=trending&pm_source=sidebar&pm_medium=web